WEKO3
アイテム
{"_buckets": {"deposit": "d31e4949-caa4-4791-9e9a-e01d5bf08b56"}, "_deposit": {"created_by": 1, "id": "84707", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "84707"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00084707", "sets": ["1"]}, "author_link": ["1022186", "1022185", "1022188", "1022182", "1022184", "1022187", "1022181", "1022183", "1022189"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2021-10", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "21", "bibliographicPageStart": "5380", "bibliographicVolumeNumber": "13", "bibliographic_titles": [{"bibliographic_title": "Cancers"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Background: Despite the large use of inhibitors of Poly-ADP ribose polymerase (PARP-I), the feasibility and safety of their combination with radiotherapy (RT) is unclear.\nAim: We conducted a literature analysis with the aim to evaluate the efficacy and safety profile of a combination with RT and PARP-I.\nMethod: The key issues for the current review were expressed in two questions according to the Population, Intervention, Control, Outcome (PICO) criteria: 1. What is the outcome and 2. What is the toxicity in patients treated with a combination of PARP-I and RT for a newly diagnosed or recurrent tumors?\nResults: A total of 12 clinical studies met the inclusion criteria including seven single-arm dose-escalation phase I studies, two phase II (two- and three-arms controlled trials) trials, one parallel-arm phase I study, and two phase I/II studies published between 2015 and 2021. RT was performed with photon beams and several schedules according to the clinical situation. The acute toxicity ≥ grade 3 ranged between 25% and \u003e96%, which was divided into hematological or non-hematological adverse events.\nConclusions: despite the heterogeneity of the evaluated patient populations and tumor types, and the limited number of the studies, this review suggests that a combination approach is feasible even though the efficacy profile remains unclear.", "subitem_description_type": "Abstract"}]}, "item_8_relation_13": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "34771545", "subitem_relation_type_select": "PMID"}}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.3390/cancers13215380", "subitem_relation_type_select": "DOI"}}]}, "item_8_relation_17": {"attribute_name": "関連サイト", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "https://www.mdpi.com/2072-6694/13/21/5380", "subitem_relation_type_select": "URI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "2072-6694", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Barcellini, Amelia"}], "nameIdentifiers": [{"nameIdentifier": "1022181", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Loap, Pierre"}], "nameIdentifiers": [{"nameIdentifier": "1022182", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Murata, Kazutoshi"}], "nameIdentifiers": [{"nameIdentifier": "1022183", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Villa, Riccardo"}], "nameIdentifiers": [{"nameIdentifier": "1022184", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kirova, Youlia"}], "nameIdentifiers": [{"nameIdentifier": "1022185", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okonogi, Noriyuki"}], "nameIdentifiers": [{"nameIdentifier": "1022186", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Orlandi, Ester"}], "nameIdentifiers": [{"nameIdentifier": "1022187", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kazutoshi, Murata", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1022188", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Noriyuki, Okonogi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1022189", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/84707", "pubdate": {"attribute_name": "公開日", "attribute_value": "2021-11-15"}, "publish_date": "2021-11-15", "publish_status": "0", "recid": "84707", "relation": {}, "relation_version_is_last": true, "title": ["PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?"], "weko_shared_id": -1}
PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?
https://repo.qst.go.jp/records/84707
https://repo.qst.go.jp/records/84707868dbc8c-1a72-4d87-828d-351169b92760
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2021-11-15 | |||||
タイトル | ||||||
タイトル | PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do? | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Barcellini, Amelia
× Barcellini, Amelia× Loap, Pierre× Murata, Kazutoshi× Villa, Riccardo× Kirova, Youlia× Okonogi, Noriyuki× Orlandi, Ester× Kazutoshi, Murata× Noriyuki, Okonogi |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Background: Despite the large use of inhibitors of Poly-ADP ribose polymerase (PARP-I), the feasibility and safety of their combination with radiotherapy (RT) is unclear. Aim: We conducted a literature analysis with the aim to evaluate the efficacy and safety profile of a combination with RT and PARP-I. Method: The key issues for the current review were expressed in two questions according to the Population, Intervention, Control, Outcome (PICO) criteria: 1. What is the outcome and 2. What is the toxicity in patients treated with a combination of PARP-I and RT for a newly diagnosed or recurrent tumors? Results: A total of 12 clinical studies met the inclusion criteria including seven single-arm dose-escalation phase I studies, two phase II (two- and three-arms controlled trials) trials, one parallel-arm phase I study, and two phase I/II studies published between 2015 and 2021. RT was performed with photon beams and several schedules according to the clinical situation. The acute toxicity ≥ grade 3 ranged between 25% and >96%, which was divided into hematological or non-hematological adverse events. Conclusions: despite the heterogeneity of the evaluated patient populations and tumor types, and the limited number of the studies, this review suggests that a combination approach is feasible even though the efficacy profile remains unclear. |
|||||
書誌情報 |
Cancers 巻 13, 号 21, p. 5380, 発行日 2021-10 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 2072-6694 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 34771545 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.3390/cancers13215380 | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | https://www.mdpi.com/2072-6694/13/21/5380 |